美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Renaissance International IPO ETF

22.20

-0.2902-1.29%

盤後：22.200.00000.00%16:10 EDT

成交量：1,125

成交額：2.50萬

市值：1,110.24萬

市盈率：- -

高：22.25

開：22.25

低：22.18

收：22.50

52周最高：26.25

52周最低：15.65

股本：50.00萬

流通股本：50.00萬

量比：0.57

換手率：0.22%

股息：0.14

股息率：0.65%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

影石創新跌3.88%創新低 2025年上市募19.4億元中信證券保薦

清越科技欺詐發行坐實：擬被罰1.72億元四名高管遭市場禁入，上市三年面臨強制退市

哈薩克斯坦開發銀行37億元離岸人民幣點心債預計9月10日在香港交易所上市，包括5年期及10年期債券兩個期限。

恒瑞醫藥：子公司卓託奇拜單抗注射液上市申請獲受理

恒瑞醫藥：HRS-7535片上市申請獲受理

北京市副市長孫碩調研北京證券交易所並主持召開北京市服務企業上市專班工作會議

恒瑞醫藥：卓託奇拜單抗注射液上市許可申請獲受理

泰諾麥博(688806.SH)：芮特韋拜單抗注射液獲批上市

泰諾麥博：芮特韋拜單抗注射液獲國家藥監局批准上市

*ST康佳A(000016.SZ)：擬主動終止上市股票停牌

ST惠程：控股子公司受讓奧利司他膠囊藥品批准文號獲批

中國AI公司Moonshot攜Kimi K3衝擊港股IPO，備戰美股的OpenAI與Anthropic面臨開放模型壓力

TradingKey中文

*ST康佳A：擬主動終止上市 9月4日起停牌

A股上市券商中報收官：合計淨賺1553.7億，淨利「百億俱樂部」擴至5家

凤凰网港股

甘肅能化：8億元科技創新公司債券將在深交所上市

隨着黃金、白銀價格上漲，在美上市貴金屬礦業企業股票盤前走高。道富黃金ETF上漲0.9%，貝萊德 iShares白銀ETF

告別「人海戰術」！上半年超半數上市銀行減員，集中在哪些崗位？

深圳商报·读创

破發股善水科技跌6.4% 上市即巔峯募14.9億中原證券保薦

破發股近岸蛋白跌12.31% 上市募18.6億國聯民生保薦

破發股希荻微跌7.21% 2022年上市即巔峯超募6.4億元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/IPOS/news?page=47"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IPOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","market":"US","secType":"STK","nameCN":"Renaissance International IPO ETF","latestPrice":22.2048,"timestamp":1789502400000,"preClose":22.495,"halted":0,"volume":1125,"hourTrading":{"tag":"盘后","latestPrice":22.2048,"preClose":22.2048,"latestTime":"16:10 EDT","volume":6,"amount":133.22879999999998,"timestamp":1789503007321,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.012900644587686251,"floatShares":500001,"shares":500001,"eps":0,"marketStatus":"盤後交易","change":-0.2902,"latestTime":"09-15 17:45:56 EDT","open":22.25,"high":22.25,"low":22.18,"amount":24999,"amplitude":0.003112,"askPrice":27.68,"askSize":100,"bidPrice":19.72,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":22.495,"sharesOutstanding":400001,"nav":22.669229,"aum":11334637.35,"dividendRate":0.006485,"bidAskSpread":0.004693,"postHourTrading":{"tag":"盘后","latestPrice":22.2048,"preClose":22.2048,"latestTime":"16:10 EDT","volume":6,"amount":133.22879999999998,"timestamp":1789503007321,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.565554,"impliedVol":0.9594,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","floatShares":500001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.565554,"shares":500001,"dividePrice":0.144,"high":22.25,"amplitude":0.003112,"preClose":22.495,"low":22.18,"week52Low":15.65,"pbRate":"--","week52High":26.25,"institutionHeld":0,"latestPrice":22.2048,"eps":0,"divideRate":0.006485,"volume":1125,"delay":0,"ttmEps":0,"open":22.25,"prevYearClose":16.8936,"prevWeekClose":22.665,"prevMonthClose":23.3188,"prevQuarterClose":25.635,"fiveDayClose":23.3527,"twentyDayClose":23.895,"sixtyDayClose":25.6848},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPOS\",params:#limit:5,,,undefined,":[{"date":"2026-09-11","symbol":"IPOS","amount":0.072205,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-11","defaultRemindTime":1789133400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-11","currency":"USD","dateTimestamp":1789099200000,"payDate":"2026-09-18"},{"date":"2026-06-12","symbol":"IPOS","amount":0.054103,"announcedDate":"2026-06-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-12","defaultRemindTime":1781271000000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-22","payableDate":"2026-06-12","currency":"USD","dateTimestamp":1781236800000,"payDate":"2026-06-22"},{"date":"2025-12-12","symbol":"IPOS","amount":0.017941,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-19"},{"date":"2025-09-12","symbol":"IPOS","amount":0.007352,"announcedDate":"2025-09-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-12","defaultRemindTime":1757683800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-12","currency":"USD","dateTimestamp":1757649600000,"payDate":"2025-09-19"},{"date":"2025-06-13","symbol":"IPOS","amount":0.13555,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-06-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPOS\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.10823,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.15245,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-22","value":0.05857,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-23","value":0.00775,"currency":"USD"},{"executeDate":"2018-06-15","recordDate":"2018-06-18","paymentDate":"2018-06-22","value":0.2024,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPOS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPOS\",pageSize:20,pageCount:47,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664386873","title":"影石創新跌3.88%創新低 2025年上市募19.4億元中信證券保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386873","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386873?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:28","pubTimestamp":1788427693,"startTime":"0","endTime":"0","summary":"中国经济网北京9月3日讯 影石创新 今日盘中最低价报108.18元，为该股上市以来最低价。截至今日收盘，该股报108.89元，跌幅3.88%。　　影石创新于2025年6月11日在上交所科创板上市，发行股票41,000,000股，发行价格为47.27元/股，保荐人为中信证券股份有限公司，保荐代表人为周鹏、刘冠中，联席主承销商为高盛、中金公司。　　影石创新首次公开发行股票发行费用合计19,030.39万元，其中，发行保荐承销费15,834.75万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260903/32359138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688775","BK0028","LU1255011170.USD","LU1997245177.USD","BK0012","LU1064131003.USD","LU1655091616.SGD","06030","LU2580892789.USD","BK1564","BK0276","LU1794554557.SGD","LU1580142542.USD","LU2148510915.USD","LU0405327148.USD","BK1516","BK1521","LU1781817850.SGD","BK0183","LU2495084118.USD","BK0196","LU1328615791.USD","BK1147","IPOS","LU1146622755.USD","BK0188","600030","LU1997245094.SGD","LU1720050803.USD","LU1997244956.HKD","LU1820825898.SGD","BK0214","LU2580892862.HKD","LU0405327494.USD","LU2289578879.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664470878","title":"清越科技欺詐發行坐實：擬被罰1.72億元 四名高管遭市場禁入，上市三年面臨強制退市","url":"https://stock-news.laohu8.com/highlight/detail?id=2664470878","media":"新浪证券","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664470878?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:27","pubTimestamp":1788427620,"startTime":"0","endTime":"0","summary":"清越科技欺诈发行情况上市之后，清越科技并未停止财务造假行为。结合欺诈发行、信息披露两项违法行为，证监会拟对清越科技责令改正、给予警告，合计罚款近1.72亿元。时任董事长高裕弟被给予警告并罚款1050万元，还被罚8年市场禁入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-09-03/doc-iniqpvfu1142826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664917878","title":"哈薩克斯坦開發銀行37億元離岸人民幣點心債預計9月10日在香港交易所上市，包括5年期及10年期債券兩個期限。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664917878","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664917878?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:20","pubTimestamp":1788427210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CYB","BNDW","RAYC","LU0107464264.USD","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878306","title":"恒瑞醫藥：子公司卓託奇拜單抗注射液上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878306","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878306?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:08","pubTimestamp":1788426480,"startTime":"0","endTime":"0","summary":"9月3日，恒瑞医药（600276/01276）发布公告，子公司广东恒瑞医药有限公司收到国家药监局下发的《受理通知书》，公司的卓托奇拜单抗注射液药品上市许可申请获国家药监局受理。卓托奇拜单抗注射液用于治疗外用药控制不佳或不适合外用药治疗的成人中重度特应性皮炎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864116562.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864116562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1064131003.USD","LU2543165471.USD","LU0359202008.SGD","LU1255011170.USD","LU2097828805.USD","LU2328871848.SGD","IPOS","LU2148510915.USD","600276","LU1969619763.USD","BK0060","LU2580892862.HKD","LU2580892789.USD","LU1820825898.SGD","LU1023057109.AUD","LU2097828631.EUR","LU2289578879.USD","LU2488822045.USD","BK1191","LU0405327494.USD","LU1997245094.SGD","LU0359201885.HKD","LU1655091616.SGD","LU1997244956.HKD","LU0359201612.USD","LU2097828714.EUR","BK0196","LU1064130708.USD","BK0183","LU2097828474.EUR","01276","BK0188","LU2495084118.USD","BK0028","LU0405327148.USD","LU1328615791.USD","LU1580142542.USD","LU1781817850.SGD","LU1146622755.USD","LU2097828557.USD","LU1997245177.USD","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664783748","title":"恒瑞醫藥：HRS-7535片上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664783748","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664783748?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:08","pubTimestamp":1788426480,"startTime":"0","endTime":"0","summary":"9月3日，恒瑞医药（600276/01276）发布公告，公司HRS-7535片的药品上市许可申请获国家药监局受理。公告提到，HRS-7535片适用于在控制饮食和增加运动基础上，初始体重指数（BMI）符合相关要求的成人的长期体重管理。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864116263.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864116263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1781817850.SGD","LU1820825898.SGD","LU2495084118.USD","LU1969619763.USD","LU2097828714.EUR","LU0405327494.USD","BK0188","LU0359201612.USD","LU2289578879.USD","LU0405327148.USD","LU1064131003.USD","LU2488822045.USD","LU2097828631.EUR","LU0359202008.SGD","LU1064130708.USD","LU1997245094.SGD","IPOS","BK0060","LU1580142542.USD","LU1328615791.USD","LU2543165471.USD","01276","LU1997244956.HKD","BK1191","LU1146622755.USD","BK0028","LU2097828474.EUR","BK0196","LU2328871848.SGD","BK0183","LU2580892862.HKD","600276","LU0359201885.HKD","LU2148510915.USD","LU1997245177.USD","LU2097828557.USD","LU1655091616.SGD","LU2580892789.USD","BK0012","BK0239","LU1255011170.USD","LU2097828805.USD","LU1023057109.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664031820","title":"北京市副市長孫碩調研北京證券交易所並主持召開北京市服務企業上市專班工作會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664031820","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664031820?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:02","pubTimestamp":1788426157,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","IAI","BK4582"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664207678","title":"恒瑞醫藥：卓託奇拜單抗注射液上市許可申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664207678","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664207678?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:01","pubTimestamp":1788426096,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664820025","title":"泰諾麥博(688806.SH)：芮特韋拜單抗注射液獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2664820025","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664820025?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:59","pubTimestamp":1788425988,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰诺麦博 发布公告，公司收到国家药品监督管理局通知，通过优先审评审批程序批准公司自主研发的1类儿童专用创新药芮特韦拜单抗注射液上市。作为公司完全自主研发的1类创新药，芮特韦拜单抗注射液项目获国家科技重大专项立项支持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688806","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664782045","title":"泰諾麥博：芮特韋拜單抗注射液獲國家藥監局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2664782045","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664782045?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:54","pubTimestamp":1788425662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664082017","title":"*ST康佳A(000016.SZ)：擬主動終止上市 股票停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664082017","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664082017?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:48","pubTimestamp":1788425332,"startTime":"0","endTime":"0","summary":"智通财经APP讯，*ST康佳A(000016.SZ)发布公告，公司拟以股东会决议方式主动撤回A股和B股股票在深圳证券交易所(简称“深交所”)的上市交易，并在股票终止上市后申请转入全国中小企业股份转让系统有限责任公司代为管理的退市板块转让。公司股票将自2026年9月4日(星期五)开市起停牌，直至深交所在公告公司股票终止上市决定之日后5个交易日内对公司股票予以摘牌，公司股票终止上市;如本次终止上市事项未获得股东会审议通过，公司将向深交所申请股票自股东会决议公告之日(2026年9月15日)起复牌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491507.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","BK0010","BK0214","BK0126","000016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664965820","title":"ST惠程：控股子公司受讓奧利司他膠囊藥品批准文號獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2664965820","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664965820?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:47","pubTimestamp":1788425224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664105873","title":"中國AI公司Moonshot攜Kimi K3衝擊港股IPO，備戰美股的OpenAI與Anthropic面臨開放模型壓力","url":"https://stock-news.laohu8.com/highlight/detail?id=2664105873","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664105873?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:44","pubTimestamp":1788425045,"startTime":"0","endTime":"0","summary":"TradingKey - 美东时间9月2日，中国AI公司月之暗面已启动港股上市程序。据路透社报道，该公司已以保密形式向香港交易所提交A1上市申请，公司方面对相关传闻不予置评。","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20260717/kimi-k3-5be3b00f00c64c1ea6b38e5faff37b61.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260717/kimi-k3-5be3b00f00c64c1ea6b38e5faff37b61.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/analysis/stocks/us-stock/262148505-moonshot-kimi3-hongkong-ipo-openai-anthropic-open-weight-pressure-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","BK4588","QTOC","AIPO","FRHC","IPOS","VXUS","BK4127","CHAT","REDS","VTHR","KCAI","BK4585","ARTY","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664208158","title":"*ST康佳A：擬主動終止上市 9月4日起停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664208158","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664208158?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:39","pubTimestamp":1788424768,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664820633","title":"A股上市券商中報收官：合計淨賺1553.7億，淨利「百億俱樂部」擴至5家","url":"https://stock-news.laohu8.com/highlight/detail?id=2664820633","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664820633?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:28","pubTimestamp":1788424127,"startTime":"0","endTime":"0","summary":"A股上市券商2026年半年度报告披露正式收官。“百亿俱乐部”扩至5家从净利润看，上半年券商净利“百亿俱乐部”已扩容至5家——中信证券、国泰海通、华泰证券、广发证券、招商证券，而2025年同期仅有2家。华泰证券以116.92亿元位列第三，但从第五名升至第四名的广发证券步步紧逼，其净利润为116.52亿元，两者差距已微乎其微。上半年，43家上市券商合计实现经纪业务手续费净收入984.48亿元，同比增长55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://original.ifeng.com/c/8w7XOJz6qO7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","IPOS","BK1147","83188","03130","83130","03188","02827","07233","399300","82846","02846","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827218","title":"甘肅能化：8億元科技創新公司債券將在深交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827218","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827218?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:27","pubTimestamp":1788424024,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827162","title":"隨着黃金、白銀價格上漲，在美上市貴金屬礦業企業股票盤前走高。道富黃金ETF上漲0.9%，貝萊德 iShares白銀ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827162?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:18","pubTimestamp":1788423514,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["DBP","GDXY","GLDM","SLVR","SLVO","ZSL","DGP","JNUG","GDXD","OUNZ","RING","GDXJ","FGDL","STBK","XME","PSLV","IAU","PMTL","FAAR","JDST","SIVR","SPPP","USG","SETM","SGDM","BEGS","SINV","SHNY","GOAU","AAAU","UGL","IPOS","AGQ","YSAG","GLL","EEMA","FDN","SLJY","GOLY","IAUI","SLVX","DZZ","BTGD","SLVP","SLVY","DBC","GDX","DULL","PICK","GLTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827964","title":"告別「人海戰術」！上半年超半數上市銀行減員，集中在哪些崗位？","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827964","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827964?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 15:57","pubTimestamp":1788422232,"startTime":"0","endTime":"0","summary":"深圳商报·读创客户端记者邱清月2026年A股上市银行中期财报披露工作已全面收官，从各家银行公示的人员在岗数据来看，年内超半数上市银行在岗员工规模较年初出现回落，国有大行、头部城商行成为人员优化调整的主要主体。国有六大行整体人员调整分化明显，其中农业银行年内人员压缩力度在行业内最为突出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864045944.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864045944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IPOS","161121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827515","title":"破發股善水科技跌6.4% 上市即巔峯募14.9億中原證券保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827515","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827515?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 15:56","pubTimestamp":1788422165,"startTime":"0","endTime":"0","summary":"中国经济网北京9月3日讯 善水科技 今日收报18.33元，跌幅6.43%。目前该股处于破发状态。　　善水科技发行募集资金总额为14.94亿元，扣除发行费用后，募集资金净额为13.84亿元，最终募集资金净额比原计划多7091.57万元。　　善水科技的保荐机构为中原证券股份有限公司，保荐代表人为汪先福、赵沂蒙。善水科技本次发行费用合计1.10亿元，中原证券股份有限公司获得承销及保荐费用9489.64万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260903/32358979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0201","601375","BK0276","301190","BK0229","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827590","title":"破發股近岸蛋白跌12.31% 上市募18.6億國聯民生保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827590","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827590?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 15:56","pubTimestamp":1788422162,"startTime":"0","endTime":"0","summary":"中国经济网北京9月3日讯 近岸蛋白 今日收报63.77元，跌幅12.31%。该股目前处于破发状态。　　近岸蛋白于2022年9月29日在上交所科创板上市，发行价格为106.19元/股，发行股票数量为1,754.3860万股，保荐人为民生证券股份有限公司，保荐代表人为王璐、黄立超。　　近岸蛋白首次公开发行股票募集资金总额为186,298.25万元，扣除发行费用后募集资金净额为174,219.58万元。　　近岸蛋白首次公开发行股票的发行费用总额为12,078.67万元，其中，承销保荐费用9,842.17万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260903/32358971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688137","BK0276","BK1147","IPOS","BK0216","601456","BK1564","01456"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827518","title":"破發股希荻微跌7.21% 2022年上市即巔峯超募6.4億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827518","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827518?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 15:56","pubTimestamp":1788422161,"startTime":"0","endTime":"0","summary":"中国经济网北京9月3日讯 希荻微 今日股价下跌，截至收盘报12.87元，跌幅7.21%。该股目前处于破发状态。　　希荻微上市首日盘中创下股价最高点51.88元，此后该股震荡走低。　　希荻微首次公开发行股票发行费用总额为1.22亿元，其中，承销费及保荐费1.02亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260903/32358970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","BK0231","688173"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":55,"pageCount":47,"totalSize":1094,"code":"91000000","status":"200"}]}}